首页 | 本学科首页   官方微博 | 高级检索  
     

双歧三联活菌胶囊对急性胰腺炎患者肠黏膜屏障功能的保护作用
引用本文:叶军,吕剑杰,潘杰锋. 双歧三联活菌胶囊对急性胰腺炎患者肠黏膜屏障功能的保护作用[J]. 中国微生态学杂志, 2014, 0(4): 441-443
作者姓名:叶军  吕剑杰  潘杰锋
作者单位:慈溪市人民医院急诊科,浙江慈溪315300
摘    要:
目的探讨双歧三联活菌胶囊对急性胰腺炎患者肠黏膜屏障功能的保护作用。方法选取急性胰腺炎患者66例,随机分为观察组和对照组。两组患者均予以禁食水、持续胃肠减压、解痉镇痛、抗感染、抑制胃酸分泌、生长抑素、改善局部微循环和保持水电解质酸碱平衡等常规治疗。观察组患者加用双歧杆菌三联活菌胶囊420mg水化后自胃管灌注,夹管1.5h,3次/d,连用7d。观察两组患者的治疗前后肠黏膜屏障功能的变化情况,并比较其临床疗效。结果治疗7d后,两组患者血清内毒素、TNF—α和D-乳酸水平均有明显下降(P〈0.05或P〈0.01),且观察组下降值比对照组更明显(P〈0.05);同时观察组患者临床总有效率为93.94%,明显高于对照组的75.76%(χ2=4.24,P〈0.05)。结论双歧杆菌三联活菌胶囊治疗急性胰腺炎效果较好,能降低血清内毒素、TNF-α和D-乳酸水平,对患者肠黏膜屏障功能具有良好的保护作用。

关 键 词:急性胰腺炎  双歧三联活菌胶囊  肠黏膜屏障

Protective effect of Bifid Triple Viable Capsules on the function of intestinal mucosal barrier of patients with acute pancreatitis
YE Jun,Lyu Jian-jie,PAN Jie-feng. Protective effect of Bifid Triple Viable Capsules on the function of intestinal mucosal barrier of patients with acute pancreatitis[J]. Chinese Journal of Microecology, 2014, 0(4): 441-443
Authors:YE Jun  Lyu Jian-jie  PAN Jie-feng
Affiliation:Emergency Department, Cixi People's Hospital, Cixi 315300, China
Abstract:
Objective To discuss the protective effect of Bifid Triple Viable Capsules on the function of intestinal mucosal barrier of patients with acute pancreatitis (AP). Methods 66 cases of patients with AP were selected and divided into observation group and control group at random. The patients in both groups were given routine medical treatment such as fasting and water deprivation, continuous gastrointestinal decompression, Antispasmodic and analgesic treatment, anti-infection, inhibition of gastric acid secretion and somatostatin, improving local micro- circulation, keeping water electrolyte and acid-base balance etc.. The patients in observation group were additionally given 420 mg Bifid Triple Viable Capsules which were perfused with stomach tube after hydration, and the tube was clamped for 1.5 hours, 3 times daily for 7 days. The changes of intestinal mucosal barrier function in both groups before and after treatment was observed, and clinical curative effect was compared. Results After 7 days' medical treatment, the serum endotoxin, TNF-α and D-Lactate levels of patients in both groups obviously declined ( P 〈 0. 05 or P 〈 0.01 ), and the declining rate in observation group was much higher than that in control group ( P 〈 0.05). The total clinical efficiency in observation group was 93.94%, much higher than that in control group (75.76%) (X2 = 4.24, P 〈 0.05 ). Conclusion Bifid Triple Viable Capsules has reliable curative effect on AP. It can reduce the serum endotoxin, TNF-α and D-Lactate levels, and has favorable protection effect on the function of intestinal mucosal barrier of patients.
Keywords:Acute pancreatitis  Bifid triple viable capsules  Intestinal mucosal barrier
本文献已被 维普 等数据库收录!
点击此处可从《中国微生态学杂志》浏览原始摘要信息
点击此处可从《中国微生态学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号